CLOVER HEALTH INVESTMENTS, CORP. /DE Derivative, Gain on Derivative
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) reported Derivative, Gain on Derivative of $93.80 million for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-01.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeGainOnDerivative · last filed 2023-03-01
- CLOVER HEALTH INVESTMENTS, CORP. /DE derivative, gain on derivative for the quarter ending 2020-12-31 was $6.30M.
- CLOVER HEALTH INVESTMENTS, CORP. /DE derivative, gain on derivative for the quarter ending 2020-09-30 was $68.10M.
- CLOVER HEALTH INVESTMENTS, CORP. /DE derivative, gain on derivative for the quarter ending 2020-06-30 was $5.20M.
- CLOVER HEALTH INVESTMENTS, CORP. /DE derivative, gain on derivative for the quarter ending 2020-03-31 was $14.20M.
- CLOVER HEALTH INVESTMENTS, CORP. /DE derivative, gain on derivative for fiscal 2020 was $93.80M.
| Period end | Derivative, Gain on Derivative 3 month | Derivative, Gain on Derivative 6 month | Derivative, Gain on Derivative 9 month | Derivative, Gain on Derivative 12 month |
|---|---|---|---|---|
| 2020-12-31 | $6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $74.40M derived: sum of 2 quarters · filed 2023-03-01 | $79.60M derived: sum of 3 quarters · filed 2023-03-01 | $93.80M 10-K · filed 2023-03-01 |
| 2020-09-30 | $68.10M 10-Q · filed 2021-11-09 | $73.30M derived: sum of 2 quarters · filed 2021-11-09 | $87.50M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $5.20M 10-Q · filed 2021-08-11 | $19.40M 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $14.20M 10-Q · filed 2021-05-17 |